chemical and pharmaceutical

Analyst Comment

EASD 2023: Effectiveness of GLP-1 Agonists vs. DPP-4Is in Patients with T2D and CKD

GLP-1RAs are increasingly the preferred therapy.

GlobalData Healthcare

Analyst Comment

Fentanyl: a horrifyingly disruptive drug

Market Data

Five largest chemical and pharmaceutical construction projects initiated globally in Q2 2022

Market Data

Asia Pacific’s five largest chemical and pharmaceutical construction projects that commenced in Q2 2022

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

EASD 2023: Effectiveness of GLP-1 Agonists vs. DPP-4Is in Patients with T2D and CKD

Fentanyl: a horrifyingly disruptive drug

Five largest chemical and pharmaceutical construction projects initiated globally in Q2 2022

Asia Pacific’s five largest chemical and pharmaceutical construction projects that commenced in Q2 2022

Leading lead generation providers and technology solutions for the pharmaceutical industry

Leading sales enablement, prospecting and automation providers and technology solutions for the pharmaceutical industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief